News

On the trail of the ‘key protein’ - New research project on the cause of pulmonary hypertension in heart failure

Pulmonary hypertension (PH) is a serious disease in which the pressure in the blood vessels between the heart and lungs is permanently increased. In…

Read more

14 DZHK scientists on the list of the world's most influential researchers

14 researchers from the DZHK have been included in the list of 'Highly Cited Researchers 2024'. The annual award honours scientists worldwide who have…

Read more

Antibodies as unrecognised key players in thrombosis - new therapeutic approaches without the risk of bleeding

A groundbreaking study by scientists at the LMU Hospital Munich and the German Centre for Cardiovascular Research has shown that antibodies and the…

Read more

Dysferlin protein protects and shapes the membrane of heart muscle cells

Researchers at the University Medical Centre Göttingen have discovered that the protein dysferlin plays a key role in protecting the heart muscle,…

Read more

German University Medicine Award goes to research team for the ‘heart patch’

This year, the German University Medicine Award goes to a research team from the University Medical Centre Göttingen (UMG) and the University Medical…

Read more

New insights into the mechanisms of venous thrombosis harbour therapeutic potential

Venous thrombosis and pulmonary embolism are among the most common cardiovascular diseases and can have life-threatening consequences. DZHK…

Read more

Prof. Daniela Panáková takes up DZHK professorship for Cardiac Genetics of Congenital Structural Heart Disease

Prof. Dr. Daniela Panáková has taken up the DZHK professorship for Cardiac Genetics of Congenital Structural Heart Disease at the University Medical…

Read more

Gerd Hasenfuß ends his academic career

Prof Gerd Hasenfuß from the University Medical Centre Göttingen was a member of the founding board of the DZHK and helped shape its fortunes for eight…

Read more

Gene Therapy Improves Heart Function in Hypertrophic Cardiomyopathy

Scientists at the University Hospital Hamburg-Eppendorf have shown that the sustained activation of tubulin tyrosination could be a novel treatment…

Read more

Volkmar Falk new President of the EACTS

Professor Volkmar Falk, Medical Director of the Deutsches Herzzentrum der Charité (DHZC) and Principal Investigator at the DZHK, was elected as the…

Read more